LOX and gastric cancer: Among the identified DEGs, we found that 7 genes (IGFBP7, LOX, NRP1, PRSS3, DPP3, EFNA3, and CD73) were also differentially expressed in tumor tissues and associated with a poor or better prognosis in patients with gastric cancer (Figure 1C).